206 related articles for article (PubMed ID: 19857784)
1. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
Liu AK; Macy ME; Foreman NK
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1148-54. PubMed ID: 19857784
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
[TBL] [Abstract][Full Text] [Related]
3. Effect of bevacizumab on radiation necrosis of the brain.
Gonzalez J; Kumar AJ; Conrad CA; Levin VA
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
[TBL] [Abstract][Full Text] [Related]
4. Single-shot bevacizumab for cerebral radiation injury.
Voss M; Wenger KJ; Fokas E; Forster MT; Steinbach JP; Ronellenfitsch MW
BMC Neurol; 2021 Feb; 21(1):77. PubMed ID: 33596839
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
Matuschek C; Bölke E; Nawatny J; Hoffmann TK; Peiper M; Orth K; Gerber PA; Rusnak E; Lammering G; Budach W
Strahlenther Onkol; 2011 Feb; 187(2):135-9. PubMed ID: 21336713
[TBL] [Abstract][Full Text] [Related]
6. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis.
Ma Y; Zheng C; Feng Y; Xu Q
J Craniofac Surg; 2017 Sep; 28(6):e569-e571. PubMed ID: 28749838
[TBL] [Abstract][Full Text] [Related]
8. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.
Foster KA; Ares WJ; Pollack IF; Jakacki RI
Pediatr Blood Cancer; 2015 Feb; 62(2):240-245. PubMed ID: 25382690
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
Lubelski D; Abdullah KG; Weil RJ; Marko NF
J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases.
Miyatake S; Furuse M; Kawabata S; Maruyama T; Kumabe T; Kuroiwa T; Ono K
Neuro Oncol; 2013 Jun; 15(6):650-5. PubMed ID: 23460324
[TBL] [Abstract][Full Text] [Related]
15. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
Furuse M; Kawabata S; Kuroiwa T; Miyatake S
J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis.
Benoit A; Ducray F; Cartalat-Carel S; Psimaras D; Ricard D; Honnorat J
J Neurol; 2011 Feb; 258(2):328-9. PubMed ID: 20862487
[No Abstract] [Full Text] [Related]
17. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation of cerebral radiation necrosis by bevacizumab.
Jeyaretna DS; Curry WT; Batchelor TT; Stemmer-Rachamimov A; Plotkin SR
J Clin Oncol; 2011 Mar; 29(7):e159-62. PubMed ID: 21149667
[No Abstract] [Full Text] [Related]
20. Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.
Aguilera DG; Mazewski C; Hayes L; Jordan C; Esiashivilli N; Janns A; Macdonald TJ
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e42-6. PubMed ID: 23249962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]